Neoplasms

All Conditions

Skin and Connective Tissue Diseases

Symptoms and General Pathology

Leiomyoma

Myofibroma

Cysts

Neoplasms, Connective and Soft Tissue

Neoplasms by Histologic Type

women presenting with thickened endometrium after the use of ulipristalacetate will undergo a saline infusion in the uterus and immediate ultrasonographic control to visualise the morphology of the endometrium.

Instillation of 10cc of saline infusion in the uterine cavity while performing an ultrasonic evaluation of the uterine cavity and endometrium.

saline infusion sonography

Catherine Degreef, PhD

If endometrial thickening is visualised (\>10mm) after the use of ulipristalacetate in case of medical treatment for uterine fibroids a saline infusion and sonographic examination will be performed to evaluate the endometrium and exclude intra-uterine pathology.

When ultrasonographic examination during follow up of a treatment with ulipristalacetate shows a thickening of the endometrium of 10mm or more ( thickening described in 10% of ulipristalacetate users and is completely benign), a saline infusion can help to exclude pathology in the uterine cavity. Saline infusion helps to better delineate the uterine cavity and endometrium. If fibroids or polyps are present in the uterine cavity they will clearly be seen.

This study was set up to describe how the endometrial changes after Esmya use appear on saline infusion sonography. This study can help to recognize ultrasonographic images in women presenting with thickened endometrium after Ulipristalacetate use.

Ultrasonographic Appearance of the Endometrium After Ulipristalacetate Use and Endometrial Changes

Ultrasonographic Appearance of the Endometrium After Saline Infusion in Women Presenting With a Thickened Endometrium After the Use of Ulipristalacetate.

thickness and appearance of the endometrium

presence yes or no of intra uterine pathology as polyps or fibroids

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Ultrasonographic Appearance of the Endometrium After Ulipristalacetate Use and Endometrial Changes	NCT04576039	Uterine Fibroid Endometrial Cys...	saline infusion...	18 Years - 50 Years	Universitair Ziekenhuis Brussel
Ultrasonographic Appearance of the Endometrium After Ulipristalacetate Use and Endometrial Changes	NCT04576039	Uterine Fibroid Endometrial Cys...	saline infusion...	18 Years - 50 Years	Universitair Ziekenhuis Brussel
Ultrasonographic Appearance of the Endometrium After Ulipristalacetate Use and Endometrial Changes	NCT04576039	Uterine Fibroid Endometrial Cys...	saline infusion...	18 Years - 50 Years	Universitair Ziekenhuis Brussel

Spots Global Cancer Trial Database for saline infusion sonography